Urogen Drug Patent Portfolio
Urogen owns 2 orange book drugs protected by 5 US patents Given below is the list of Urogen's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12268745 | Material and method for treating internal cavities | 20 Jan, 2031 | Active |
| US9040074 | Material and method for treating internal cavities | 20 Jan, 2031 | Active |
| US9950069 | Material and method for treating internal cavities | 20 Jan, 2031 | Active |
| US10039832 | Material And Method For Treating Internal Cavities | 20 Jan, 2031 | Active |
| US12440568 | Material And Method For Treating Internal Cavities | 20 Jan, 2031 | Active |
Latest Legal Activities on Urogen's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Urogen.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Dispatch to FDC | 19 Sep, 2025 | US12440568 |
| Application Is Considered Ready for Issue | 19 Sep, 2025 | US12440568 |
| Issue Fee Payment Received | 18 Sep, 2025 | US12440568 |
| Issue Fee Payment Verified | 18 Sep, 2025 | US12440568 |
| Supplemental Papers - Oath or Declaration | 17 Sep, 2025 | US12440568 |
| Filing Receipt - Corrected | 05 Sep, 2025 | US12440568 |
| Email Notification | 05 Sep, 2025 | US12440568 |
| Mail Notice of Allowance | 26 Aug, 2025 | US12440568 |
| Notice of Allowance Data Verification Completed | 24 Aug, 2025 | US12440568 |
| Information Disclosure Statement considered | 19 Aug, 2025 | US12440568 |
| Electronic Information Disclosure Statement | 14 Aug, 2025 | US12440568 |
| Information Disclosure Statement (IDS) Filed | 14 Aug, 2025 | US12440568 |
| track 1 ON | 13 Aug, 2025 | US12440568 |
| Date Forwarded to Examiner | 13 Aug, 2025 | US12440568 |
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED | 06 Aug, 2025 | US12440568 |
Urogen's Family Patents
Urogen Drug List
Given below is the complete list of Urogen's drugs and the patents protecting them.
1. Jelmyto
Jelmyto is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12268745 | Material and method for treating internal cavities |
20 Jan, 2031
(4 years from now)
| Active |
| US9040074 | Material and method for treating internal cavities |
20 Jan, 2031
(4 years from now)
| Active |
| US9950069 | Material and method for treating internal cavities |
20 Jan, 2031
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jelmyto's drug page
2. Zusduri
Zusduri is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10039832 | Material And Method For Treating Internal Cavities |
20 Jan, 2031
(4 years from now)
| Active |
| US12440568 | Material And Method For Treating Internal Cavities |
20 Jan, 2031
(4 years from now)
| Active |
| US9040074 | Material and method for treating internal cavities |
20 Jan, 2031
(4 years from now)
| Active |
| US9950069 | Material and method for treating internal cavities |
20 Jan, 2031
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zusduri's drug page